Skip to main content

#151325

Anti-Rad52 [FBE3]

Cat. #151325

Anti-Rad52 [FBE3]

Cat. #: 151325

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Rad52

Class: Polyclonal

Application: IP ; WB ; FACS ; IP ; WB

Reactivity: Human

Host: Rabbit

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Stephen West

Institute: Cancer Research UK, London Research Institute: Clare Hall Laboratories

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Rad52 [FBE3]
  • Research fields: Genetics
  • Clone: FBE3
  • Tool sub type: Primary antibody
  • Class: Polyclonal
  • Conjugation: Unconjugated
  • Reactivity: Human
  • Host: Rabbit
  • Application: IP ; WB ; FACS ; IP ; WB
  • Description: RAD52 is a recombinase, binds RAD51 and is a component of the homologous recombination DNA repair pathway.
  • Immunogen: Purified full length recombinant His-tagged Rad52.

Target Details

  • Target: Rad52
  • Target background: RAD52 is a recombinase, binds RAD51 and is a component of the homologous recombination DNA repair pathway.

Applications

  • Application: IP ; WB ; FACS ; IP ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: Whole serum
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Ahn et al. 2015. Nucleic Acids Res. 43(13):6321-33. PMID: 26068472.
  • Tang et al. 2014. PLoS One. 9(11):e111584. PMID: 25365323.
  • Muylaert et al. 2010. J Biol Chem. 285(18):13761-8. PMID: 20215648.
  • Masson et al. 1999. EMBO J. 18(22):6552-60. PMID: 10562567.
  • The meiosis-specific recombinase hDmc1 forms ring structures and interacts with hRad51.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.